Boehringer Ingelheim

8. Boehringer Ingelheim

Total Ad Spend: $174.7 million
Television: $119.6 million
Magazine: $54.7 million
Other: $363,740

The private company put its mouth where its money is, so to speak, talking up the two drugs that are its best sellers.

In the spotlight


Spiriva, $89.8 million
Pradaxa, $80.4 million


 

Boehringer Ingelheim
Read more on

Suggested Articles

Companies considering this avenue must think through potential implications despite the obvious attraction of early access for patients.

BD says a $1.2 billion investment in its pre-filled syringe business will add surge capacity needed to meet demand in future pandemics.

Ad Environment Matters for Message Receptivity